Advertisement
Research Article| Volume 55, ISSUE 2, P82-90, August 2009

Exposure of human keratinocytes to ischemia, hyperglycemia and their combination induces oxidative stress via the enzymes inducible nitric oxide synthase and xanthine oxidase

      Abstract

      Background

      Diabetes mellitus is characterized by a chronic hyperglycemia and might cause skin pathologies resulting from an ischemic insult. A variety of mechanisms have been suggested for the damage provided by ischemia-reperfusion injury (IRI) or for hyperglycemic conditions. Yet, the association between IRI and hyperglycemia together in skin has been poorly investigated even thought they are both present in diabetic patients.

      Objective

      To examine the effect of a dual stress combining IRI and hyperglycemia on human keratinocytes—its ability to cause oxidative damage and inflammatory response via the enzymes xanthine oxidase (XO) and inducible nitric oxide synthase (iNOS).

      Methods

      HaCaT cells were used as a model to induce IRI and hyperglycemia. In order to assess the oxidative damage, total antioxidant scavenging capacity (TSC) and GSH/GSSG ratio were evaluated. iNOS expression was evaluated and its metabolite nitric oxide was estimated by measuring nitrite levels. XO activity was assessed by uric acid quantification and by superoxide radical formation. Inflammatory response was determined through interleukin-6 secretion.

      Results

      Our observations demonstrate different responses of the cells exposed to single stress (IRI) compared to dual stress combining also hyperglycemia. However, cells response exhibited similarity during reperfusion, by enhancing iNOS expression as well as superoxide levels. While ischemia led to changes in TSC and redox state, reperfusion restored them to basal levels. IRI also caused the enhancement of secreted IL-6 and uric acid levels.

      Conclusion

      iNOS and XO play a major role in IRI and hyperglycemia. Inhibition of one of these enzymes may be beneficial to skin cells under these conditions.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Dermatological Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Wohlrab J.
        • Wohlrab D.
        • Meiss F.
        Skin diseases in diabetes mellitus.
        J Dtsch Dermatol Ges. 2007; 5: 37-53
        • Sheetz M.J.
        • King G.L.
        Molecular understanding of hyperglycemia's adverse effects for diabetic complications.
        JAMA. 2002; 288: 2579-2588
        • Ellis E.A.
        • Guberski D.L.
        • Hutson B.
        • Grant M.B.
        Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat.
        Nitric Oxide. 2002; 6: 295-304
        • Pacher P.
        • Obrosova I.G.
        • Mabley J.G.
        • Szabo C.
        Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.
        Curr Med Chem. 2005; 12: 267-275
        • Hunt J.V.
        • Dean R.T.
        • Wolff S.P.
        Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing.
        Biochem J. 1988; 256: 205-212
        • Nishikawa T.
        • Edelstein D.
        • Du X.L.
        • Yamagishi S.
        • Matsumura T.
        • Kaneda Y.
        • et al.
        Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.
        Nature. 2000; 404: 787-790
        • Van den Enden M.K.
        • Nyengaard J.R.
        • Ostrow E.
        • Burgan J.H.
        • Williamson J.R.
        Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism. Implications for diabetic retinopathy.
        Invest Ophthalmol Vis Sci. 1995; 36: 1675-1685
        • Haffner S.M.
        • Greenberg A.S.
        • Weston W.M.
        • Chen H.
        • Williams K.
        • Freed M.I.
        Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
        Circulation. 2002; 106: 84-679
        • Kristiansen O.P.
        • Mandrup-Poulsen T.
        Interleukin-6 and diabetes: the good, the bad, or the indifferent?.
        Diabetes. 2005; 54: S114-S124
        • Crockett E.T.
        • Galligan J.J.
        • Uhal B.D.
        • Harkema J.
        • Roth R.
        • Pandya K.
        Protection of early phase hepatic ischemia-reperfusion injury by cholinergic agonists.
        BMC Clin Pathol. 2006; 6: 3
        • Yassin M.M.
        • Harkin D.W.
        • Barros D'Sa A.A.
        • Halliday M.I.
        • Rowlands B.J.
        Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction.
        World J Surg. 2002; 26: 115-121
        • Chalmers-Redman R.M.
        • Fraser A.D.
        • Ju W.Y.
        • Wadia J.
        • Tatton N.A.
        • Tatton W.G.
        Mechanisms of nerve cell death: apoptosis or necrosis after cerebral ischaemia.
        Int Rev Neurobiol. 1997; 40: 1-25
        • Droge W.
        Free radicals in the physiological control of cell function.
        Physiol Rev. 2002; 82: 47-95
        • Engerson T.D.
        • McKelvey T.G.
        • Rhyne D.B.
        • Boggio E.B.
        • Snyder S.J.
        • Jones H.P.
        Conversion of xanthine dehydrogenase to oxidase in ischemic rat tissues.
        J Clin Invest. 1987; 79: 1564-1570
        • McCord J.M.
        Oxygen-derived free radicals in postischemic tissue injury.
        N Engl J Med. 1985; 312: 159-163
        • Kohen R.
        • Nyska A.
        Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification.
        Toxicol Pathol. 2002; 30: 620-650
        • Cuzzocrea S.
        • Riley D.P.
        • Caputi A.P.
        • Salvemini D.
        Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury.
        Pharmacol Rev. 2001; 53: 135-159
        • Beckman J.S.
        Oxidative damage and tyrosine nitration from peroxynitrite.
        Chem Res Toxicol. 1996; 9: 836-844
        • Abd-El-Aleem S.A.
        • Ferguson M.W.
        • Appleton I.
        • Kairsingh S.
        • Jude E.B.
        • Jones K.
        • et al.
        Expression of nitric oxide synthase isoforms and arginase in normal human skin and chronic venous leg ulcers.
        J Pathol. 2000; 191: 42-434
        • Ferdinandy P.
        Peroxynitrite: just an oxidative/nitrosative stressor or a physiological regulator as well?.
        Br J Pharmacol. 2006; 148: 1-3
        • Halliwell B.
        • Gutteride J.M.
        Free radicals in Biology and medicine.
        Oxford University Press, Avon1999
        • Richeson C.
        • Mulder P.
        • Bowry V.
        • Ingold K.
        The complex chemistry of peroxynitrite decomposition: new insight.
        J. Am. Chem. 1998; 120: 7211-7219
        • Szabo C.
        Multiple pathways of peroxynitrite cytotoxicity.
        Toxicol Lett. 2003; 140-141: 105-112
        • Portugal M.
        • Kohen R.
        Peroxynitrite: a key molecule in skin tissue response to different types of stress.
        in: Valacchi J. Davis P.A. Oxidants in biology—a question of balance. Springer, Netherlands2008: 19-36
        • Abu Raya S.
        • Trembovler V.
        • Shohami E.
        • Lazarovici P.
        A tissue culture ischemic device to study eicosanoid release by pheochromocytoma PC12 cultures.
        J Neurosci Methods. 1993; 50: 197-203
        • Tabakman R.
        • Lazarovici P.
        • Kohen R.
        Neuroprotective effects of carnosine and homocarnosine on pheochromocytoma PC12 cells exposed to ischemia.
        J Neurosci Res. 2002; 68: 463-469
        • Koren E.
        • Zverev I.
        • Ginsburg I.
        • Kohen R.
        Supplementation with antioxidants fails to increase the total antioxidant capacity of several cell lines in culture.
        Biomed Pharmacother. 2008; 62: 179-188
        • Bradford M.M.
        A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
        Anal Biochem. 1976; 72: 248-254
        • Mosmann T.
        Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.
        J Immunol Methods. 1983; 65: 55-63
        • Slater T.F.
        • Sawyer B.
        • Straeuli U.
        Studies on succinate-tetrazolium reductase systems. iii. Points of coupling of four different tetrazolium salts.
        Biochim Biophys Acta. 1963; : 383-393
        • Cao G.
        • Verdon C.P.
        • Wu A.H.
        • Wang H.
        • Prior R.L.
        Automated assay of oxygen radical absorbance capacity with the COBAS FARA II.
        Clin Chem. 1995; 41: 1738-1744
        • Prior R.L.
        • Hoang H.
        • Gu L.
        • Xu X.
        • Bacchiocca M.
        • Howard L.
        • et al.
        Assays for hydrophilic and lipophilic antioxidant capacity (oxygen radical absorbance capacity (ORAC(FL))) of plasma and other biological and food samples.
        J Agric Food Chem. 2003; 51: 3273-3279
        • Shilo S.
        • Aronis A.
        • Komarnitsky R.
        • Tirosh O.
        Selenite sensitizes mitochondrial permeability transition pore opening in vitro and in vivo: a possible mechanism for chemo-protection.
        Biochem J. 2003; 370: 283-290
        • Motchnik P.A.
        • Frei B.
        • Ames B.N.
        Measurement of antioxidants in human blood plasma.
        Methods Enzymol. 1994; 234: 269-279
        • Misko T.P.
        • Schilling R.J.
        • Salvemini D.
        • Moore W.M.
        • Currie M.G.
        A fluorometric assay for the measurement of nitrite in biological samples.
        Anal Biochem. 1993; 214: 11-16
        • Wang P.
        • Wu P.
        • Siegel M.I.
        • Egan R.W.
        • Billah M.M.
        Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms.
        J Biol Chem. 1995; 270: 9558-9563
        • Abramov Y.
        • Schenker J.G.
        • Lewin A.
        • Friedler S.
        • Nisman B.
        • Barak V.
        Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome.
        Hum Reprod. 1996; 11: 1381-1386
        • Catrina S.B.
        • Okamoto K.
        • Pereira T.
        • Brismar K.
        • Poellinger L.
        Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function.
        Diabetes. 2004; 53: 3226-3232
        • Halliwell B.
        • Whiteman M.
        Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?.
        Br J Pharmacol. 2004; 142: 231-255
        • Ghiselli A.
        • Serafini M.
        • Natella F.
        • Scaccini C.
        Total antioxidant capacity as a tool to assess redox status: critical view and experimental data.
        Free Radic Biol Med. 2000; 29: 1106-1114
        • Huang D.
        • Ou B.
        • Prior R.L.
        The chemistry behind antioxidant capacity assays.
        J Agric Food Chem. 2005; 53: 1841-1856
        • Prior R.L.
        • Cao G.
        In vivo total antioxidant capacity: comparison of different analytical methods.
        Free Radic Biol Med. 1999; 27: 1173-1181
        • Sies H.
        Total antioxidant capacity: appraisal of a concept.
        J Nutr. 2007; 137: 1493-1495
        • Nishino T.
        • Nakanishi S.
        • Okamoto K.
        Conversion of xanthine dehydrogenase into oxidase and its role in reperfusion injury.
        Biochem Soc Trans. 1997; 25: 783-786
        • Daniliuc S.
        • Bitterman H.
        • Rahat M.A.
        • Kinarty A.
        • Rosenzweig D.
        • Lahat N.
        Hypoxia inactivates inducible nitric oxide synthase in mouse macrophages by disrupting its interaction with alpha-actinin 4.
        J Immunol. 2003; 171: 3225-3232
        • Kristian T.
        Metabolic stages, mitochondria and calcium in hypoxic/ischemic brain damage.
        Cell Calcium. 2004; 36: 221-233
        • Halliwell B.
        Reactive oxygen species and the central nervous system.
        J Neurochem. 1992; 59: 1609-1623
        • Li C.
        • Jackson R.M.
        Reactive species mechanisms of cellular hypoxia-reoxygenation injury.
        Am J Physiol Cell Physiol. 2002; 282: C227-C241
        • Go Y.M.
        • Jones D.P.
        Redox compartmentalization in eukaryotic cells.
        Biochim Biophys Acta. 2008; 1780: 1273-1290
        • Khamaisi M.
        • Kavel O.
        • Rosenstock M.
        • Porat M.
        • Yuli M.
        • Kaiser N.
        • et al.
        Effect of inhibition of glutathione synthesis on insulin action: in vivo and in vitro studies using buthionine sulfoximine.
        Biochem J. 2000; 349: 579-586
        • MacGowan S.W.
        • Regan M.C.
        • Malone C.
        • Sharkey O.
        • Young L.
        • Gorey T.F.
        • et al.
        Superoxide radical and xanthine oxidoreductase activity in the human heart during cardiac operations.
        Ann Thorac Surg. 1995; 60: 1289-1293
        • Squadrito G.L.
        • Cueto R.
        • Splenser A.E.
        • Valavanidis A.
        • Zhang H.
        • Uppu R.M.
        • et al.
        Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid.
        Arch Biochem Biophys. 2000; 376: 333-337
        • Layton M.E.
        • Wood J.G.
        • Yan Z.Y.
        • Forster J.
        Ischemia/reperfusion alters uric acid and ascorbic acid levels in liver.
        J Surg Res. 1996; 64: 1-5
        • Chamorro A.
        • Obach V.
        • Cervera A.
        • Revilla M.
        • Deulofeu R.
        • Aponte J.H.
        Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke.
        Stroke. 2002; 33: 1048-1052
        • Marletta M.A.
        Nitric oxide synthase: function and mechanism.
        Adv Exp Med Biol. 1993; 338: 281-284
        • Nathan C.
        • Xie Q.W.
        Regulation of biosynthesis of nitric oxide.
        J Biol Chem. 1994; 269: 13725-13728
        • Stamler J.S.
        Redox signaling: nitrosylation and related target interactions of nitric oxide.
        Cell. 1994; 78: 931-936
        • Millar T.M.
        • Stevens C.R.
        • Benjamin N.
        • Eisenthal R.
        • Harrison R.
        • Blake D.R.
        Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions.
        FEBS Lett. 1998; 427: 225-228
        • Kuo Y.R.
        • Wang F.S.
        • Jeng S.F.
        • Lutz B.S.
        • Huang H.C.
        • Yang K.D.
        Nitrosoglutathione improves blood perfusion and flap survival by suppressing iNOS but protecting eNOS expression in the flap vessels after ischemia/reperfusion injury.
        Surgery. 2004; 135: 437-446
        • Luo J.D.
        • Wang Y.Y.
        • Fu W.L.
        • Wu J.
        • Chen A.F.
        Gene therapy of endothelial nitric oxide synthase and manganese superoxide dismutase restores delayed wound healing in type 1 diabetic mice.
        Circulation. 2004; 110: 2484-2493
        • Crack P.J.
        • Taylor J.M.
        Reactive oxygen species and the modulation of stroke.
        Free Radic Biol Med. 2005; 38: 1433-1444
        • Kimizuka K.
        • Nakao A.
        • Nalesnik M.A.
        • Demetris A.G.
        • Uchiyama T.
        • Ruppert K.
        • et al.
        Exogenous IL-6 inhibits acute inflammatory responses and prevents ischemia/reperfusion injury after intestinal transplantation.
        Am J Transplant. 2004; 4: 482-494